Alzheimer’s Disease and Diabetes: Risk, “Type 3” Myth & Care

Written by: Dr. Albana Greca Sejdini, MD, MMedSc, Family Physician

Medically reviewed by: Dr. Ruden Cakoni, MD, Endocrinologist

Last reviewed: July 2026

Quick Answer

Diabetes and Alzheimer’s disease are not the same condition. However, diabetes is associated with a higher risk of cognitive decline, Alzheimer’s disease, vascular dementia, and mixed dementia. Long-term high glucose, repeated severe low glucose, stroke and small-vessel damage, high blood pressure, and abnormal cholesterol may all contribute. The phrase “type 3 diabetes” is not an official medical diagnosis and should not be used as another name for Alzheimer’s disease.

When patients ask me whether diabetes “causes” Alzheimer's disease, I explain that the relationship is real but not simple. Having diabetes does not mean you will develop Alzheimer's, and many people with Alzheimer's have never had diabetes. What we do know is that diabetes is associated with a higher risk of several types of dementia, while blood pressure, cholesterol, smoking, physical activity, sleep, hearing, age, and genetics also matter.

The American Diabetes Association's 2026 Standards of Care emphasize that older adults with diabetes have higher rates of cognitive impairment and dementia and recommend regular cognitive screening from age 65. This matters because memory and thinking problems can also make diabetes self-care more difficult, especially when insulin, glucose monitoring, meal timing, or medicines are complex.

What Is Alzheimer’s Disease?

Alzheimer’s disease is a progressive brain disorder that gradually affects memory, thinking, language, judgment, and the ability to manage daily life. It is the most common cause of dementia, but it is not the only one.

Dementia is a syndrome, not one single disease. It describes a decline in cognitive abilities severe enough to interfere with everyday activities. Other causes include vascular dementia, Lewy body dementia, frontotemporal dementia, and mixed dementia. In mixed dementia, more than one disease process—often Alzheimer changes together with blood-vessel damage—may be present.

Normal aging may involve occasionally forgetting a name and remembering it later. Dementia is different. Examples include repeatedly asking the same question, getting lost in familiar places, being unable to manage medicines or bills, or experiencing progressive changes in language, behavior, and judgment.

What Happens in the Brain?

Alzheimer’s disease develops through a complex interaction of changes that begin years before obvious symptoms. Two important proteins are beta-amyloid and tau.

  • Beta-amyloid can collect between nerve cells and form plaques.
  • Tau normally helps stabilize the internal transport system of nerve cells. In Alzheimer’s disease, abnormal tau can form tangles inside cells.

These changes are associated with disrupted communication between nerve cells, inflammation, loss of connections, and eventually cell death and brain shrinkage. Alzheimer’s is not explained by amyloid or tau alone; genetics, age, blood vessels, immune activity, and other biological processes also contribute.

Large observational studies show that people with diabetes have a higher average risk of dementia than people without diabetes. The American Diabetes Association notes associations with all-cause dementia, Alzheimer’s disease, and vascular dementia. An association does not prove that diabetes alone caused the dementia, because age, cardiovascular disease, education, sleep, activity, smoking, and other factors may also influence risk.

Possible pathway How it may affect the brain What may help
Blood-vessel damage Diabetes can increase the risk of stroke and small-vessel disease, contributing to vascular or mixed dementia. Manage blood pressure, LDL cholesterol, smoking, glucose, and physical activity.
Long-term high glucose Persistent hyperglycemia is associated with inflammation, oxidative stress, and vascular injury. Use an individualized diabetes plan and attend regular reviews.
Severe or repeated hypoglycemia Low glucose can temporarily impair brain function; severe episodes and cognitive decline may reinforce one another. Review insulin and medicines, use glucose alerts when appropriate, and keep a treatment plan for lows.
Insulin signaling and metabolism Researchers are studying how insulin resistance and altered energy use may affect brain cells. This remains a developing field. Focus on established cardiovascular and diabetes care rather than unproven “brain insulin” cures.

The relationship also works in the other direction: cognitive impairment can make diabetes harder to manage. A person may forget meals, repeat a medicine dose, misread a glucose result, or struggle to use insulin safely. That is why the diabetes plan should become simpler and safer when memory or executive function declines.

Is Alzheimer’s Disease “Type 3 Diabetes”?

No. “Type 3 diabetes” is not an official diagnosis recognized as a diabetes type, and Alzheimer’s disease should not be renamed diabetes.

Researchers and the media sometimes use the phrase when discussing possible insulin resistance or metabolic dysfunction in the brain. It is a hypothesis-oriented shorthand, not a clinical diagnosis. It does not mean that a person with Alzheimer’s has high brain sugar, should take diabetes medicine for dementia, or can reverse Alzheimer’s by following a diabetes diet. No supplement, herb, elixir, or glucose-lowering medicine has been proven to cure Alzheimer’s disease.

Infographic explaining that diabetes may increase Alzheimer’s and dementia risk but Alzheimer’s disease is not type 3 diabetes
Diabetes can affect dementia risk through glucose and cardiovascular pathways, but Alzheimer’s disease and diabetes are not the same condition.

Who Is More Likely to Develop Alzheimer’s Disease?

Age is the strongest known risk factor, but Alzheimer’s is not a normal or unavoidable part of aging. Risk is shaped by a combination of factors.

Factors you cannot change

  • Older age
  • Family history and certain genetic variants
  • Down syndrome
  • Some prior neurological conditions

Factors that may be modified

  • Diabetes and unsafe glucose patterns
  • High blood pressure and high LDL cholesterol
  • Smoking, physical inactivity, and excess alcohol
  • Obesity, depression, and social isolation
  • Untreated hearing or vision loss
  • Head injury and air pollution exposure

Reducing a risk factor does not guarantee prevention. It can, however, support brain and cardiovascular health. The 2024 Lancet Commission estimated that addressing 14 modifiable factors could potentially prevent or delay a substantial proportion of dementia cases at the population level. This is a modeling estimate, not a promise for any one person.

Symptoms and Stages of Alzheimer’s Disease

Symptoms usually develop gradually and become more noticeable over time. Memory difficulty is common, but some people first show problems with language, visual-spatial skills, planning, or judgment.

Early or mild stage

  • Repeating questions or forgetting recent conversations
  • Difficulty finding words, planning tasks, or managing money and medicines
  • Getting lost or confused in familiar places
  • Reduced judgment, initiative, or social engagement

Moderate stage

  • More severe memory and language problems
  • Needing help with dressing, bathing, meals, or medications
  • Sleep disruption, wandering, agitation, suspiciousness, or hallucinations
  • Difficulty recognizing people or understanding surroundings

Severe or late stage

  • Extensive assistance needed for all daily activities
  • Limited speech and mobility
  • Difficulty swallowing, incontinence, and increased infection risk

Stage descriptions are general. Progression and symptoms vary widely, and another illness can temporarily make cognition much worse.

Sudden Confusion Is Not Typical Gradual Alzheimer’s

A sudden change over minutes or hours may be an emergency. Possible causes include hypoglycemia, stroke, very high glucose with dehydration, infection, medication effects, seizure, or delirium.

  • Check glucose immediately if it is safe to do so.
  • Call emergency services for facial droop, one-sided weakness, trouble speaking, sudden vision loss, severe headache, seizure, fainting, inability to swallow, or unconsciousness.
  • Severely low glucose—below 54 mg/dL (3.0 mmol/L)—requires immediate treatment. If the person cannot safely swallow, use prescribed glucagon if available and call emergency services.
  • Seek urgent care for very high glucose with confusion, vomiting, marked dehydration, or deep or rapid breathing.

See the guide to dangerous blood sugar levels and emergency warning signs.

How Is Alzheimer’s Disease Diagnosed?

There is no single home test that can diagnose Alzheimer’s disease. Assessment normally combines several pieces of evidence:

  1. Medical history: The clinician asks when symptoms began, how they changed, and how they affect daily activities. Information from a family member or caregiver is often valuable.
  2. Cognitive and functional testing: This checks memory, attention, language, problem-solving, orientation, and everyday independence.
  3. Physical and neurological examination: The clinician looks for signs that might suggest stroke, Parkinsonism, or another cause.
  4. Medication, mood, sleep, hearing, and vision review: Depression, sleep disorders, sensory loss, and some medicines may worsen thinking.
  5. Laboratory tests: Tests may include thyroid function, vitamin B12, blood count, kidney or liver function, glucose, and others chosen for the individual.
  6. Brain imaging: CT or MRI can identify stroke, tumor, fluid buildup, or patterns of brain loss. PET imaging or spinal-fluid tests may be used in selected patients.

Blood-based Alzheimer biomarkers are entering clinical use. In 2025, the U.S. FDA cleared the first blood test to assist diagnosis in adults aged 55 and older who already have signs or symptoms. It is an adjunct to a full evaluation—not a stand-alone screening test for healthy people.

The American Diabetes Association recommends considering screening for mild cognitive impairment or dementia in adults with diabetes aged 65 or older at the initial visit and annually when appropriate. A new concern at any age deserves evaluation rather than waiting for the next routine visit.

Alzheimer’s Disease Treatment Options

There is currently no cure that restores all lost memory or stops every case from progressing. Treatment aims to maintain function, ease symptoms, slow decline in selected patients, support caregivers, and protect safety.

Medicines for cognitive symptoms

Cholinesterase inhibitors—including donepezil, rivastigmine, galantamine, and benzgalantamine—may help cognition or daily function for some people, especially in mild to moderate disease. Memantine may be used in moderate to severe Alzheimer’s disease. Benefits and side effects vary, so these medicines need individualized review.

Anti-amyloid treatments for selected early disease

Lecanemab and donanemab are disease-modifying antibody treatments for selected people with mild cognitive impairment or mild dementia due to Alzheimer’s disease and confirmed amyloid pathology. Clinical trials showed that they modestly slowed decline over the study period; they did not cure Alzheimer’s or restore abilities already lost.

These treatments can cause amyloid-related imaging abnormalities, called ARIA, including brain swelling or bleeding. Specialists consider MRI findings, other medicines such as blood thinners, and genetic factors such as APOE ε4. MRI monitoring is required. A neurologist or memory specialist should determine whether potential benefit outweighs risk.

Non-drug care

  • Regular routines and clear medication organization
  • Physical activity adapted to ability and fall risk
  • Cognitive stimulation, occupational therapy, and meaningful activities
  • Treatment of pain, depression, sleep problems, hearing loss, and vision loss
  • Home-safety assessment, driving review, and wandering precautions
  • Caregiver education, respite support, and advance-care planning

Managing Diabetes When Memory Declines

Diabetes care should be made safer as cognition changes. A complex plan that once worked well may become dangerous if the person forgets meals, repeats doses, or cannot interpret glucose readings.

  • Simplify the regimen: Ask the diabetes clinician whether dosing, injection timing, or the number of daily decisions can be reduced.
  • Prioritize hypoglycemia prevention: Review insulin and sulfonylureas, kidney function, appetite, weight loss, and previous low-glucose episodes.
  • Individualize A1C and glucose targets: Tighter is not always safer in frailty, dementia, or high hypoglycemia risk.
  • Involve a trusted caregiver: Use a written schedule, pill organizer, pharmacy packs, supervised injections, or shared glucose alerts when appropriate.
  • Keep meals and hydration regular: Poor appetite, missed meals, swallowing difficulty, and dehydration can destabilize glucose.
  • Consider continuous glucose monitoring: CGM alarms and caregiver data sharing may help some insulin users, but the device must remain manageable.

Do not stop insulin or change diabetes doses without clinical guidance. The goal is steady, safe glucose—not perfect numbers. Review general blood glucose targets, then ask the treating clinician how they should be adapted.

Can Dementia Risk Be Reduced?

No plan can guarantee that Alzheimer’s disease will be prevented. Still, the steps that protect the heart and blood vessels also support brain health:

  • Manage glucose safely and avoid repeated severe lows.
  • Check and treat blood pressure and LDL cholesterol.
  • Use prescribed medicines consistently and review them regularly.
  • Be physically active; combine aerobic, strength, balance, and flexibility work as appropriate.
  • Do not smoke, and avoid excess alcohol.
  • Protect the head during sports, cycling, work, and fall-risk activities.
  • Treat depression and sleep problems, including possible sleep apnea.
  • Correct hearing and vision problems rather than accepting them as “just aging.”
  • Stay socially connected and mentally engaged in enjoyable, meaningful activities.

A balanced lifestyle is more evidence-based than any single “memory food” or supplement. Physical activity, nutritious meals, adequate sleep, social contact, and control of cardiovascular risks work together. Read more about exercise with diabetes and the broader guide to preventing diabetes complications.

Doctor’s Note

When a patient with diabetes develops memory problems, I do not assume that diabetes or Alzheimer’s is automatically the cause. I first consider the timeline and reversible contributors: glucose extremes, medication effects, thyroid or vitamin problems, depression, sleep, infection, hearing, vision, and stroke. Early assessment matters because it can improve safety, identify treatable problems, and help the family plan before a crisis occurs.

Most Asked Questions

Does diabetes cause Alzheimer’s disease?

Diabetes is associated with higher dementia risk, but it does not directly or inevitably cause Alzheimer’s. Risk is influenced by age, genetics, blood vessels, glucose patterns, and many other health and lifestyle factors.

Can metformin prevent or treat Alzheimer’s disease?

Metformin treats type 2 diabetes; it is not an approved treatment for Alzheimer’s disease. Research on diabetes medicines and dementia has produced mixed or incomplete results. Take metformin for the indication prescribed, and do not start it as a memory treatment.

Can high blood sugar cause memory problems?

Very high glucose can cause fatigue, dehydration, poor concentration, or acute confusion. Long-term hyperglycemia is also associated with vascular and cognitive risk. New or worsening memory problems still need a full assessment rather than being attributed to glucose alone.

Can low blood sugar look like dementia?

Yes. Hypoglycemia can cause sudden confusion, unusual behavior, irritability, speech difficulty, seizure, or loss of consciousness. It usually develops much faster than Alzheimer’s symptoms. Check glucose promptly and treat according to the person’s emergency plan.

Should everyone with diabetes be tested for Alzheimer’s?

Not everyone needs specialized biomarker testing. Cognitive screening is especially important in older adults and whenever the patient, family, or clinician notices a decline. Abnormal screening should lead to a proper diagnostic evaluation.

Can Alzheimer’s disease be prevented?

There is no guaranteed prevention. Managing diabetes, blood pressure, cholesterol, activity, smoking, hearing, vision, depression, and social isolation may reduce or delay dementia risk and benefits overall health.

Related Questions From Readers

Related Resources

References

  1. American Diabetes Association. Older Adults: Standards of Care in Diabetes—2026.
  2. American Diabetes Association. Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Care in Diabetes—2026.
  3. National Institute on Aging. What Happens to the Brain in Alzheimer’s Disease?
  4. National Institute on Aging. What Are the Signs of Alzheimer’s Disease?
  5. National Institute on Aging. How Is Alzheimer’s Disease Diagnosed?
  6. National Institute on Aging. How Is Alzheimer’s Disease Treated?
  7. U.S. Food and Drug Administration. FDA Clears First Blood Test Used in Diagnosing Alzheimer’s Disease.
  8. U.S. Food and Drug Administration. Additional MRI Monitoring for Patients Taking Lecanemab.
  9. U.S. Food and Drug Administration. FDA Approves Donanemab for Adults With Alzheimer’s Disease.
  10. Livingston G, et al. Dementia Prevention, Intervention, and Care: 2024 Report of the Lancet Standing Commission.

Medical disclaimer: Educational only—not personal medical advice. Do not change diabetes or memory medicines without your clinician. Seek emergency care for sudden confusion, stroke symptoms, seizure, unconsciousness, or a severe glucose emergency.